Search results for "BLAST"

showing 10 items of 2136 documents

Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification

2007

Multisystem Langerhans cell histiocytosis (MS-LCH) is associated with high mortality when patients have risk organ involvement (RO+) or are younger than 2 years. In an international randomized trial, LCH-II, we intensified their treatment: arm A consisted of 6 weeks of daily prednisone and weekly vinblastine followed by 18 weeks of daily 6-mercaptopurine with vinblastine/prednisone pulses; etoposide was added in arm B. Considering all 193 randomized risk patients, there were similar outcomes: rapid (6 weeks) response (arm A vs arm B: 63%/71%), 5-year survival probability (74%/79%), disease reactivation frequency (46%/46%), and permanent consequences (43%/37%). However, (1) patients younger …

Malemedicine.medical_specialtyImmunologyAdult Langerhans Cell HistiocytosisBiochemistryGastroenterologylaw.inventionLangerhans cell histiocytosisRandomized controlled trialRisk FactorsPrednisonelawInternal medicineHumansMedicineEtoposideDemographyHematologybusiness.industryInfantCell BiologyHematologymedicine.diseaseSurgeryVinblastineSurvival RateHistiocytosis Langerhans-CellTreatment OutcomeChild PreschoolOrgan involvementFemalebusinessmedicine.drugBlood
researchProduct

Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1β in osteoarthritic osteobla…

2011

Osteoarthritis (OA) is a chronic degenerative joint disease showing altered bone metabolism. Osteoblasts contribute to the regulation of cartilage metabolism and bone remodeling. We have shown previously that induction of heme oxygenase-1 (HO-1) protects OA cartilage against inflammatory and degradative responses. In this study, we investigated the effects of HO-1 induction on OA osteoblast metabolism. HO-1 was induced with cobalt protoporphyrin IX (CoPP) and by transduction with LV-HO-1. In osteoblasts stimulated with interleukin (IL)-1β, CoPP enhanced mineralization, the expression of a number of markers of osteoblast differentiation such as Runx2, bone morphogenetic protein-2, osteocalci…

Malemedicine.medical_specialtyInterleukin-1betaCartilage metabolismBiochemistryBone remodelingOsteoprotegerinInternal medicineOsteoarthritismedicineHumansCells CulturedCellular SenescenceOsteitisAgedPharmacologyOsteoblastsbiologyChemistryInterleukinOsteoblastMiddle AgedCOPPHeme oxygenaseMetabolismmedicine.anatomical_structureEndocrinologyOsteocalcinbiology.proteinFemaleInflammation MediatorsHeme Oxygenase-1Biochemical Pharmacology
researchProduct

Massive pulmonary embolism in a young boy with T-cell leukaemia. Successful thrombolytic therapy by recombinant tissue plasminogen activator (rtPA).

2014

SummaryAcute pulmonary embolism (PE) is a serious complication in association with malignant diseases. We describe the successful treatment of PE applying a systemic thrombolytic therapy in a 4-year-old boy with acute lymphoblastic leukaemia.The thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) 0.1 mg/ kg bodyweight per hour for six hours was continued for six days without important side effects. In particular no bleeding complications were observed. Computed tomography with contrast revealed a remarkable regression of the central PE. Without further delays the chemotherapy was resumed.

Malemedicine.medical_specialtyLeukemia T-Cellmedicine.medical_treatmentComputed tomographyFibrinolytic AgentsmedicineHumansRecombinant tissue plasminogen activatorChemotherapymedicine.diagnostic_testbusiness.industryAnticoagulantsHematologyHeparin Low-Molecular-Weightmedicine.diseaseRecombinant ProteinsSurgeryPulmonary embolismTreatment OutcomeChild PreschoolTissue Plasminogen ActivatorLymphoblastic leukaemiaDrug Therapy CombinationbusinessComplicationPulmonary EmbolismT cell leukaemiaHamostaseologie
researchProduct

A 12-year-old boy with severe back pain and blast-like cells in the CSF

1999

Malemedicine.medical_specialtyLumbar Vertebraebusiness.industryLymphoblastCentral nervous systemBack anatomyMagnetic Resonance ImagingSurgeryCerebrospinal fluidmedicine.anatomical_structureEl NiñoBack PainPediatrics Perinatology and Child HealthmedicineHumansSevere back painLymphocytesBorrelia InfectionsChildbusinessEuropean Journal of Pediatrics
researchProduct

Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience

2016

Therapy for post-transplant relapse of paediatric ALL is limited. Standardised curative approaches are not available. We hereby describe our local procedure in this life-threatening situation. A total of 101 ALL patients received their first allogeneic stem cell transplantation (SCT) in our institution. After relapse, our primary therapeutic goal was to cure the patient with high-dose chemotherapy or specific immunotherapy (HDCHT/SIT) followed by a second SCT from a haploidentical donor (transplant approach). If this was not feasible, low-dose chemotherapy and donor lymphocyte infusions (LDCHT+DLI) were offered (non-transplant approach). A total of 23 patients suffered a post-transplant rel…

Malemedicine.medical_specialtyLymphocyte TransfusionAdolescentmedicine.medical_treatment03 medical and health sciences0302 clinical medicineRecurrenceGermanymedicineHumansProgenitor cellChildRetrospective StudiesTransplantationChemotherapybusiness.industryInfantRetrospective cohort studyHematologyImmunotherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaAllograftsmedicine.diseaseTissue DonorsSurgeryTransplantationClinical trialsurgical procedures operativeGraft-versus-host diseaseChild PreschoolLymphocyte Transfusion030220 oncology & carcinogenesisFemaleImmunotherapybusinessStem Cell Transplantation030215 immunologyBone Marrow Transplantation
researchProduct

Indication and technique for the reconstruction of nerve defects in head and neck.

1974

Summary Although the results of peripheral nerve repair have been greatly improved in the last years following the introduction of microsurgery and increased application of free autologous nerve transplants, the use of restorative neuroplasty in maxillofacial surgery has been limited. Prompted by the successful reports on modern neuroplasty, we have introduced the use of autologous nerve transplant to bridge lesions of various cranial nerves. Our experience is based on the treatment of traumatic and tumour-induced defects of the facial nerve, inferior alveolar nerve, accessory and lingual nerve. The anastomosis of nerve was accomplished exclusively under the surgical microscope and microsur…

Malemedicine.medical_specialtyMicrosurgeryAccessory nerveAdolescentmedicine.medical_treatmentAccessory Nerve InjuriesMandibular NerveLingual NerveInferior alveolar nerveAnastomosisTransplantation AutologousAmeloblastomaLingual Nerve InjuriesAccessory NerveSural NervemedicineHumansLingual nerveCervical PlexusFacial Nerve Injuriesbusiness.industryCranial nervesCranial NervesPeripheral Nervous System DiseasesGeneral MedicineMicrosurgeryFacial nerveSurgeryFacial NerveMandibular NeoplasmsSpinal NervesAnesthesiaTooth ExtractionNeck DissectionSurgeryTrigeminal Nerve InjuriesEpineurial repairbusinessJournal of maxillofacial surgery
researchProduct

Stage 4 s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry

2019

Background Infants diagnosed with stage 4 s neuroblastoma commonly experience spontaneous disease regression, with few succumbing without response to therapy. We analyzed a large cohort of such infants enrolled in the Italian Neuroblastoma Registry to detect changes over time in presenting features, treatment and outcome. Methods Of 3355 subjects aged 0–18 years with previously untreated neuroblastoma diagnosed between 1979 and 2013, a total of 280 infants (8.3%) had stage 4 s characteristics, 268 of whom were eligible for analyses. Three treatment eras were identified on the basis of based diagnostic and chemotherapy adopted. Group 1 patients received upfront chemotherapy; Group 2 and 3 pa…

Malemedicine.medical_specialtyMultivariate analysisAdolescentmedicine.medical_treatmentLiver transplantationPrognostic factorsPediatricsCohort Studies03 medical and health sciencesNeuroblastoma0302 clinical medicineStage 4 s030225 pediatricsInternal medicineNeuroblastomamedicineHumansRegistries030212 general & internal medicineElevated ldhStage (cooking)Risk factorChildMale genderStage 4 sNeoplasm StagingChemotherapybusiness.industryResearchInfant Newbornlcsh:RJ1-570Infantlcsh:PediatricsPerinatology and Child Healthmedicine.diseaseSurvival RateInfants; Neuroblastoma; Prognostic factors; Stage 4 s; Pediatrics Perinatology and Child HealthItalyChild PreschoolFemalebusinessInfantsItalian Journal of Pediatrics
researchProduct

Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study

2014

The outcome of high-risk (HR) Acute Lymphoblastic Leukemia (ALL) patients enrolled in AIEOP-BFM ALL 2000 study (NCT00613457) in Italy is described. Overall, 1999 Philadelphia negative ALL patients entered the study. HR criteria were: minimal residual disease (MRD) levels ≥10-3 at day 78 (HR-MRD), no complete remission (no-CR) at day 33, t(4;11) translocation, Prednisone Poor Response (PPR). Treatment (2 years) included protocol I, 3 polychemotherapy blocks, delayed intensification (protocol IIx2 or IIIx3), cranial radiotherapy, maintenance. 312 HR patients (15.6% of the total) had 5-year event-free survival (EFS) and overall survival (OS) of 58.9%(SE 2.8) and 68.9%(2.6). In hierarchical ord…

Malemedicine.medical_specialtyNeoplasm ResidualAdolescentmedicine.medical_treatmentImmunologyChromosomal translocationhigh riskacute lymphoblastic leukemiaHematopoietic stem cell transplantationBiochemistryGastroenterologyAdolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child Preschool; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Neoplasm Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy; Remission Induction; Treatment Outcome; Hematology; Biochemistry; Cell Biology; ImmunologyPrednisonehemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy Protocolshigh risk; acute lymphoblastic leukemiaHumansMedicineNeoplasmPreschoolChildChemotherapyAntineoplastic Combined Chemotherapy ProtocolRadiotherapybusiness.industryRemission InductionHematopoietic Stem Cell TransplantationInfantCell BiologyHematologyPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseCombined Modality TherapyMinimal residual diseaseSurgeryClinical trialRadiation therapyTreatment OutcomeN/ASettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAResidualChild PreschoolNeoplasmFemalebusinessHumanmedicine.drugBlood
researchProduct

Case Control Study of Neuroblastoma in West-Germany after the Chernobyl Accident

1996

Background To explore possible causes of a 1988 incidence peak of infant neuroblastoma in west German regions which were contaminated with more than 6000 Bq/m2 Cs137 from the Chernobyl accident. The primary working hypothesis was that parents of the diseased children had been contaminated by an excessive intake of locally produced food, especially mushrooms or deer. Design Case control study with 1:2 (cases:controls) matching. Data were collected from the children's parents by questionnaires and telephone interviews. Setting Nation-wide study (former FRG) based on the German Childhood Cancer Registry. Subjects Cases born in 1988 and reported with a neuroblastoma to the registry until March …

Malemedicine.medical_specialtyNeoplasms Radiation-InducedCross-sectional studyPopulationCohort StudiesNeuroblastomaPregnancyRisk FactorsGermanyEpidemiologyConfidence IntervalsmedicineHumanseducationFood Contamination RadioactiveChildhood Cancer Registryeducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Case-control studyInfantSurgeryCross-Sectional StudiesEl NiñoChild PreschoolPrenatal Exposure Delayed EffectsPediatrics Perinatology and Child HealthFemaleRadioactive Hazard ReleaseUkrainebusinessPower PlantsDemographyCohort studyKlinische Pädiatrie
researchProduct

Acute intermittent nicotine treatment produces a reduction in the total number of FGF-2 immunoreactive astroglial cells in the substantia nigra of th…

2004

To understand the morphological substrate of the nicotine effect on nigral FGF-2 expression, a stereological analysis of FGF-2 immunoreactive neuronal and glial profiles has been performed in the substantia nigra of the rat after acute intermittent nicotine treatment. The major finding of this paper is the demonstration that this type of nicotine treatment produces a significant reduction in the total number of nuclear FGF-2 immunoreactive astroglial profiles in the substantia nigra. A parallel analysis of nigral FGF-1 and FGF-5 immunoreactivities showed no effect of this type of nicotine treatment. The results may be explained by an inhibition of FGF-2 synthesis in a subpopulation of nigra…

Malemedicine.medical_specialtyNicotineCentral nervous systemFGF-2Substantia nigraStereologyFGF-1Cell CountBiologyFibroblast growth factornicotine; FGF-2; stereology; immunoreactivity; substantia nigra; FGF-1; FGF-5FGF-5NicotineRats Sprague-DawleyStereotaxic TechniquesInternal medicinemedicineAnimalsGeneral NeuroscienceAlkaloidImmunohistochemistryRatsSubstantia Nigramedicine.anatomical_structureEndocrinologyNicotinic agonistnervous systemsubstantia nigraAstrocytesStereotaxic techniquestereologyFibroblast Growth Factor 2immunoreactivitymedicine.drugnicotineNeuroscience letters
researchProduct